With a series of acquisitions and recent product approvals, St. Jude Medical has further solidified its place as a leading provider of treatment options for patients suffering from chronic pain and the symptoms associated with movement disorders. This educational supplement provides a thorough look at some of the highlights from within St. Jude Medical’s neuromodulation portfolio, focusing on new product features and providing insight from key physicians from across international markets.
[pdfviewer width=”100%” height=”940px” beta=”true”]https://neuronewsinternational.com/wp-content/uploads/sites/3/2016/02/NN_St-Jude-Supplement-low-res.pdf[/pdfviewer]
